一项全面的单细胞RNA转录组分析确定了老化骨肌肉中独特的SPP1+巨子组
Wen Bi1, Mengyue Yang2, Mengjia Shi3
1Department of Sports Medicine, The Sixth Affiliated Hospital of Shenzhen University, Shenzhen Nanshan People's Hospital, Shenzhen, 518052, China.
Scientific reports
|August 5, 2024
概括
老化骨肌肉显示SPP1+巨细胞增加,与衰老和脂肪积累有关. 达沙替尼 + 奎尔塞丁的老化治疗减少了这些巨细胞,为与年龄相关的肌肉衰弱提供了潜在的治疗标.
科学领域:
- 细胞衰老 细胞衰老
- 肌肉生物学 肌肉生物学
- 免疫学 免疫学 免疫学
背景情况:
- 骨肌肉 (SkM) 衰老有助于与年龄相关的衰弱和残疾.
- 在SkM内的巨细胞 (Mac) 种群在衰老中发挥着不同的作用.
- 损坏和修复过程之间的不平衡与SkM功能下降有关.
研究的目的:
- 为了比较新陈代谢途径和细胞的生物功能在年轻和老老鼠的SkM.
- 在老年SkM中识别和描述特定的巨细胞子组.
- 研究向与衰老相关的巨细胞的治疗潜力.
主要方法:
- 综合单细胞转录组分析年轻和老老鼠的SkM.
- 巨细胞子组的识别和表征.
- 在小鼠四头肌中对SPP1+巨细胞比例的定量分析.
- 评估老年治疗药物组合 (达沙替尼 + 奎尔塞丁) 的影响.
主要成果:
- 在老老鼠的SkM中发现了一种表达高水平SPP1的独特的巨子组,表现出衰老和脂肪生成特征.
- 在老老鼠的四头肌中,SPP1+巨细胞的比例显著增加.
- 达沙替尼 + 奎尔塞丁的老年治疗组合显著降低了SPP1+巨细胞的比例.
结论:
- SPP1+巨体代表着与SkM衰老和脂肪生成相关的独特细胞组成部分.
- 用达沙替尼 + 奎尔塞丁等老化剂向SPP1+巨细胞可能为SkM衰老提供了一种新的治疗策略.
- 这项研究强调了SPP1+巨细胞作为对抗与年龄相关的肌肉衰退的潜在老年治疗标.
更多相关视频
09:49Isolation of Region-specific Microglia from One Adult Mouse Brain Hemisphere for Deep Single-cell RNA Sequencing
Published on: December 3, 2019
10.8K
11:02Author Spotlight: Investigating Cellular and Molecular Dynamics During Muscle Regeneration Using Cutting-Edge Single-Cell Technologies
Published on: December 1, 2023
993
相关概念视频
Formation of Muscle Fibers from Myoblasts
5.8K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.8K
Somatic to iPS Cell Reprogramming
2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
Chromatin Modification in iPS Cells
1.5K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.5K
